Fig. 2.
Structures of anti-TNF agents.
Infliximab is a mouse–human chimeric monoclonal anti-TNF antibody of IgG1 isotype. Adalimumab and golimumab are fully human IgG1 monoclonal anti-TNF antibodies. Etanercept is a fusion protein of the extracellular domain of TNF-R2 and the Fc region of IgG1. Certolizumab pegol is a PEGylated Fab′ fragment of humanized monoclonal anti-TNF antibody.
